On Thursday, JPMorgan Chase & Co. (NYSE:JPM)’s shares declined -0.21% to $66.59.
J.P. Morgan Asset Administration declared that its newest ETF, the JPMorgan Diversified Return Europe Equity ETF (JPEU), will officially start trading recently. Further expanding J.P. Morgan’s planned beta suite, JPEU is the fifth product offered since the launch in June 2014.
JPEU is designed to serve as the foundation of a developed Europe equity portfolio, combining portfolio construction with stock selection in an effort to produce higher returns with lower volatility than traditional market cap-weighted indices. Similar to its predecessors, the ETF seeks to diversify risk across sectors and build a portfolio that excludes expensive, low quality companies with weak momentum characteristics.
The ETF tracks the FTSE Developed Europe Diversified Factor Index, which is rebalanced on a quarterly basis and was thoughtfully constructed based on J.P. Morgan’s active insights and risk administration expertise. The fund is managed by an practiced J.P. Morgan team, with James Ford and Richard Morillot as co-managers. J.P. Morgan has been investing in European markets since 1964 and manages $37B in European equities.
“The European recovery provides a growth opportunity for long-term investors,” said Robert Deutsch, Global Head of ETFs for J.P. Morgan Asset Administration. “JPEU is constructed to allow investors to take part in the upside while also providing less volatility in down markets. We are happy to combine the investment expertise of J.P. Morgan with the index design capabilities of FTSE Russell, to create a product that will be attractive to investors looking for exposure to European markets, but are concerned with volatility.”
JPMorgan Chase & Co. is a financial services firm. The company operates through four segments: Consumer and Community Banking, Corporate and Investment Bank, Commercial Banking, and Asset Administration.
Merck & Co., Inc. (NYSE:MRK)’s shares dropped -0.25% to $52.85. With its recent share price change, MRK market value has reached roughly $147.64 billion. Its most recent quarter balance sheet showed the company is standing at a 1.60 current ratio and possess -0.58 as debt to equity ratio. The company has a Profit Margin (ttm) of positive 27.10% and has 63.70% gross margins. The operating profit margin is 16.10%. The stock’s performance in 1 month is -0.32% and its volatility for the same period is 1.54%.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
FS Investment Corporation (NYSE:FSIC)‘s shares surged 0.98% to $9.30.
Franklin Square Capital Partners, the largest manager of business development companies (BDCs), declared the origination of a new senior secured loan to Pittsburgh Glass Operates, LLC (PGW), a leading North American manufacturer, supplier and distributor of automotive glass products.
PGW is a portfolio company of Kohlberg & Co (Kohlberg), a New York-based private equity firm focused on the middle market. The financing was offered by FS Investment Corporation (FSIC), FS Investment Corporation II (FSIC II) and FS Investment Corporation III (FSIC III), BDCs managed by associates of Franklin Square and sub-advised by GSO / Blackstone Debt Funds Administration LLC, an associate of GSO Capital Partners LP (GSO).
“We are happy to provide a customized credit solution to a leader in the automotive glass industry like Pittsburgh Glass Operates,” said Michael C. Forman, Chairman and Chief Executive Officer of FSIC, FSIC II and FSIC III.
FS Investment Corporation is a non-diversified, closed-end administration investment company. The Company’s investment objectives are to generate current income and a long-term capital appreciation. Its portfolio comprises of investments in senior secured loans and second lien secured loans of private middle market United States companies and subordinated loans of private United States companies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.